Skip to main content
Be The Investor
BTI Market Newsstock
Back to News

Banco Bilbao Vizcaya Argentaria (BME:BBVA) Draws Options Attention, Is The Stock Fully Valued?

Banco Bilbao Vizcaya Argentaria (BME:BBVA) Draws Options Attention, Is The Stock Fully Valued?

Banco Bilbao Vizcaya Argentaria has delivered strong returns and attracted options interest, but investors must weigh a €21.95 fair value against a €38.50 DCF estimate, capital catalysts, and Mexico, Turkey and regulatory risks.

Banco Bilbao Vizcaya Argentaria (BME:BBVA) is attracting attention after its September 18, 2026 €25.00 call option recorded some of the highest implied volatility across equity options trading on August 14. At a share price of €24.95, BBVA’s 30-day share-price return is 13.05%, while its one-year total shareholder return is 57.72%. Its five-year total shareholder return is close to five times the initial investment. The most followed Simply Wall St valuation narrative assigns BBVA a fair value of €21.95, implying the shares are 13.7% overvalued at €24.95. That view incorporates projected revenue expansion, a slimmer margin profile and a richer earnings multiple. The capital-return case rests on regulatory-approved simplification of risk models, notably changes to IRB models, and capital-management innovations. These measures are expected to release significant CET1 capital, optimize risk-weighted-asset density, increase shareholder distributions and support return on equity growth. However, concentrated exposure to Mexico and Turkey, alongside tighter capital rules, could undermine that thesis. The SWS DCF model offers a contrasting conclusion, estimating future cash-flow value at €38.50. On that basis, the shares trade about 35.2% below estimated value. Investors must therefore assess which assumptions are more credible: the €21.95 fair value or the €38.50 DCF estimate. Investors should also review the three key rewards and three important warning signs. Broader Simply Wall St screens include 106 top founder-led companies, 260 high-quality undervalued stocks, 441 dividend fortresses and 303 resilient stocks with low-risk scores. This commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not financial advice or a recommendation to buy or sell. It does not consider individual objectives or financial circumstances and may not include the latest price-sensitive announcements or qualitative information. Simply Wall St has no position in BBVA.MC.

Loading market context

Continue your BBVA research